Treace Medical Concepts Inc (NAS:TMCI)
$ 8.55 -0.23 (-2.62%) Market Cap: 532.64 Mil Enterprise Value: 534.29 Mil PE Ratio: 0 PB Ratio: 5.06 GF Score: 40/100

Treace Medical Concepts Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 09:30PM GMT
Release Date Price: $20.06 (-1.96%)
Unidentified Analyst

Okay. Good afternoon, everyone. I want to thank you all for being here today. Closing out -- we're approaching the close of Wednesday at the JPMorgan Healthcare Conference. I'm really excited to be introducing some members of Treace's management team, specifically CEO, John Treace; and CFO, Mark Hair. After the prepared remarks, I'll be running a Q&A. (Operator Instructions)

And with that, John, I will leave the rest to you.

John T. Treace
Treace Medical Concepts, Inc. - CEO, Founder & Director

Well, good afternoon, everyone, and thanks for having us, [Alan]. We're excited at the opportunity to tell the Treace Medical story here at the 40th Annual JPMorgan Healthcare Conference. Here are standard disclosures.

So Treace Medical is a high-growth med tech company with a unique market opportunity and business strategy. First, we're the only company 100% focused on the surgical management of bunions and related pathologies. And at $5 billion plus, our U.S. market opportunity represents one of the largest in orthopedics and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot